Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy

被引:23
作者
Lee, SC
Hua, CC
Yu, TJ
Shieh, WB
See, LC
机构
[1] Chang Gung Mem Hosp, Div Infect Dis, Dept Chest, Chilung 204, Taiwan
[2] Chang Gung Univ, Dept Publ Hlth, Linkou, Taiwan
关键词
anti-microbial therapy; nosocomial pneumonia; risk factors;
D O I
10.1111/j.1742-1241.2005.00281.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nosocomial pneumonia is a common nosocomial infection and has high mortality rate. Risk factors of mortality of nosocomial pneumonia were studied in 132 hospitalised patients who developed nosocomial pneumonia. The overall mortality rate was 64/132, 48.5%. Of the 11 risk factors univariately associated with mortality due to nosocomial pneumonia, only the inappropriate initial anti-microbial therapy, high simplified acute physiology score and multiple organ failures remained significant after stepwise logistic regression. Gram-negative bacilli were still the most pre-dominant causative microbiologic agents of nosocomial pneumonia with Pseudomonas aeruginosa (20.3%), Acineto-bacter baumannii (18.6%) and Escherichia coli (5.9%) being the three most predominant pathogens. A. baumannii were significantly more predominant among non-survivors than survivors (13.56 vs. 5.08%, p = 0.0418). The incidence rate of methicillin-resistant Staphylococcus aureus was 19.5% higher than previous reports. We conclude that inappropriate initial anti-microbial therapy for nosocomial pneumonia is associated with the mortality rate of nosocomial pneumonia, and appropriate anti-microbial therapy improves outcome of nosocomial pneumonia. (C) 2005 Blackwell Publishing Ltd.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 31 条
[1]  
AIMIRALL J, 1995, CHEST, V107, P511
[2]  
[Anonymous], 1989, AM REV RESPIR DIS, V139, P1058
[3]  
Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711
[4]   NOSOCOMIAL PNEUMONIA - A MULTIVARIATE-ANALYSIS OF RISK AND PROGNOSIS [J].
CELIS, R ;
TORRES, A ;
GATELL, JM ;
ALMELA, M ;
RODRIGUEZROISIN, R ;
AGUSTIVIDAL, A .
CHEST, 1988, 93 (02) :318-324
[5]  
Craven D E, 1987, Semin Respir Infect, V2, P20
[6]   PREVENTING NOSOCOMIAL PNEUMONIA - STATE-OF-THE-ART AND PERSPECTIVES FOR THE 1990S [J].
CRAVEN, DE ;
STEGER, KA ;
BARBER, TW .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S44-S53
[7]  
CRAVEN DE, 1986, AM REV RESPIR DIS, V133, P792
[8]   NOSOCOMIAL PNEUMONIA IN INTUBATED PATIENTS GIVEN SUCRALFATE AS COMPARED WITH ANTACIDS OR HISTAMINE TYPE-2 BLOCKERS - THE ROLE OF GASTRIC COLONIZATION [J].
DRIKS, MR ;
CRAVEN, DE ;
CELLI, BR ;
MANNING, M ;
BURKE, RA ;
GARVIN, GM ;
KUNCHES, LM ;
FARBER, HW ;
WEDEL, SA ;
MCCABE, WR .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (22) :1376-1382
[9]   CHARACTERIZATION OF INTENSIVE-CARE UNIT PATIENTS USING A MODEL-BASED ON THE PRESENCE OR ABSENCE OF ORGAN DYSFUNCTIONS AND OR INFECTION - THE ODIN MODEL [J].
FAGON, JY ;
CHASTRE, J ;
NOVARA, A ;
MEDIONI, P ;
GIBERT, C .
INTENSIVE CARE MEDICINE, 1993, 19 (03) :137-144
[10]   Nosocomial pneumonia and mortality among patients in intensive care units [J].
Fagon, JY ;
Chastre, J ;
Vuagnat, A ;
Trouillet, JL ;
Novara, A ;
Gibert, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11) :866-869